Home > Quotes > NUS

Nu Skin Enterprises, Inc. Stock Quote & Summary Data

NUS 
$62.23
*  
0.09
  negative  
0.14%
Get NUS Alerts
*Delayed - data as of Jun. 19, 2013 13:13 ET 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NUS Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored

1 Year Target: 65
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today’s trading to the average daily volume. 1,001,548
Previous Close: $ 62.32
52 Week High /Low: $ 63.57 / $ 32.36
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 3,635,005,519
P/E Ratio: 16.91
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 14.46
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 3.68
Annualized dividend $ 1.20
Ex Dividend Date May 22, 2013
Dividend Payment Date Jun. 12, 2013
Current Yield 1.93 %
Beta 1.04

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

ETFs with NUS as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
1.1% TrimTabs Float Shrink ETF (TTFS) +6.55  (18.50%)

We make it easy to follow the leaders. PowerShares QQQ. 100 companies at the top of innovation in one fund.


*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.

**Green highlights the top performing ETF by % change in the past 100 days.

 Company Description (as filed with the SEC)

We are a leading, global direct selling company founded in 1984, with operations in 53 markets worldwide. We develop and distribute innovative, premium-quality anti-aging personal care products and nutritional supplements under our Nu Skin and Pharmanex category brands, respectively. Over the last several years, we have introduced new Pharmanex nutritional supplements and Nu Skin personal care products under our ageLOC anti-aging brand. We strive to secure competitive advantages in four key areas: our people, our products, the culture we promote, and the business opportunities we offer. In 2012, we posted record revenue of $2.2 billion, representing growth of 24% percent year-over-year. - 1 - -------------------------------------------------------------------------------- TABLE OF CONTENTS We operate in the direct selling channel, primarily utilizing person-to-person marketing to market and sell our products.  ... More ...  



News Headlines for NUS

 

Consensus Recommendation